FDA Drug Application (021713) for ABILIFY by OTSUKA

Back to FDA Applications sponsored by OTSUKA

Application Number021713
Product Number001
FormSOLUTION;ORAL
Dosage1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameABILIFY
Active IngredientARIPIPRAZOLE

Active IngredientCount
List of drugs with Active Ingredient ARIPIPRAZOLE3


Back to FDA Applications sponsored by OTSUKA